Hiroomi Tada
2022
In 2022, Hiroomi Tada earned a total compensation of $1.3M as Chief Medical Officer at Tyra Biosciences, a 50% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $215,600 |
---|---|
Option Awards | $563,937 |
Salary | $486,250 |
Other | $950 |
Total | $1,266,737 |
Tada received $563.9K in option awards, accounting for 45% of the total pay in 2022.
Tada also received $215.6K in non-equity incentive plan, $486.3K in salary and $950 in other compensation.
Rankings
In 2022, Hiroomi Tada's compensation ranked 2,570th out of 5,707 executives tracked by ExecPay. In other words, Tada earned more than 55.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,570 | 55th |
Manufacturing | 1,421 | 54th |
Chemicals And Allied Products | 644 | 54th |
Drugs | 598 | 54th |
Pharmaceutical Preparations | 428 | 55th |
Tada's colleagues
We found three more compensation records of executives who worked with Hiroomi Tada at Tyra Biosciences in 2022.